Australia markets open in 5 hours 55 minutes

Navidea Biopharmaceuticals, Inc. (NO1A.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
0.06650.0000 (0.00%)
As of 09:33AM CEST. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

Currency in USD. All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
0.61
14.645
45.615
118.725
26.618
Cost of revenue
50.036
184.947
0
1.048
6.667
Gross profit
-49.426
-170.302
45.615
117.677
19.951
Operating expenses
Research development
5,093
5,970
5,142
4,930
5,338
Selling general and administrative
5,037
7,962
7,450
6,695
6,275
Total operating expenses
10,130
13,881
12,106
10,829
10,982
Operating income or loss
-10,180
-14,051
-12,060
-10,711
-10,963
Interest expense
-
1,098
6.361
-
-
Total other income/expenses net
1,569
-27.939
351.885
-21.854
-7.613
Income before tax
-8,607
-15,177
-11,715
-10,722
-10,945
Income tax expense
-
0
16.043
0
0.707
Income from continuing operations
-8,607
-15,177
-11,731
-10,722
-10,946
Net income
-1,182
-15,177
-11,731
-10,722
-10,948
Net income available to common shareholders
-1,389
-17,215
-11,731
-11,386
-10,948
Basic EPS
-
-0.56
-0.40
-0.48
-0.76
Diluted EPS
-
-0.56
-0.40
-0.48
-0.76
Basic average shares
-
30,902
29,344
23,896
14,393
Diluted average shares
-
30,902
29,344
23,896
14,393